Dr. Samapika Routray

Dr. Samapika Routray

Addl. Prof.
Dentistry

dent_samapika@aiimsbhubaneswar.edu.in

Biosketch

0

PUBLICATIONS

0

CITATIONS

0

H INDEX

PERSONAL INFORMATION

Dr. Samapika Routray

Addl. Prof.

Dentistry

Degree / Diploma Name of the University/ Institution Subject Year of Passing
BDS 2004 VMLJIDS, Utkal University
MDS 2010 Oral Pathology and Microbiology D Y PATIL University, Pune, Maharashtra
PhD 2019 Dental Sciences SOA University, Bhubaneswar, Odisha

  • ICMR DHR Longterm fellowship-University of California ,USA ,2023
  • Short term Fellowship, Institute of Surgical Pathology University Hospital, Zurich, 2015
  • Study Exchange program cum Vocational Training, University of Michigan, USA ROTARY FOUNDATION, 2012
  • Distinction in Pedodontics and Preventive Dentistry, Utkal University, 2003

International

  1. Verma S, Dasukil S, Namdev Sable M, Routray S. Radicular variant of dens in dente (RDinD) in a patient undergoing radioisotope therapy. J Taibah Univ Med Sci. 2022 May 14;17(6):1094-1098.
  2. Patel K, Bhat FA, Patil S, Routray S, Mohanty N, Nair B, Sidransky D, Ganesh MS, Ray JG, Gowda H, Chatterjee A. Whole-Exome Sequencing Analysis of Oral Squamous Cell Carcinoma Delineated by Tobacco Usage Habits. Front Oncol. 2021 May 31;11:660696.
  3. Bhat, F. A., …., Routray S.,…et al. Proteomic alterations associated with oral cancer patients with tobacco using habits. OMICS.2021.
  4. Routray S*, Kumar R, Datta KK, Puttamallesh VN, Chatterjee A, Gowda H, Mohanty N, Dash R, Dixit A. An integrated approach for identification of a panel of candidate genes arbitrated for invasion and metastasis in oral squamous cell carcinoma. Sci Rep. 2021;11(1):6208.
  5. Mohanty V, ……, Routray S, …et al. Molecular alterations in oral cancer using high-throughput proteomic analysis of formalin-fixed paraffin-embedded tissue. J Cell Commun Signal. 2021.
  6. Sahu S, Routray S*. Assessing the analytical efficacy of TEX in diagnosing oral cancer using a systematic review approach. J Oral Pathol Med. 2021;50(2):123-128.
  7. Routray S*, Mishra P. A probable surge in oral lichen planus cases under the aura of coronavirus in females in India. Oral Oncol. 2020;109:104714.
  8. Routray S*, Adhya AK, John J, Dikhit P. Revealing a rare inflammatory oral manifestation in a 6-year- old child. BMJ Case Rep. 2019;12(7):e229483.
  9. Routray S*. How far can regulating TRIM16 help reduce malignant transformation of OPMD’s to OSCC? Oral Oncol. 2019;90:123.
  10. Routray S*, Dikhit PS, Rajani BC, Khan MM. Can topical 5-fluorouracil be used as a viable treatment option for oral premalignant lesions and tumors? Oral Oncol. 2019;91:128.
  1. Routray S*. Time to tame necroptosis – viable combat against chemo resistant oral cancer cells. Oncol Rev. 2018;12(1):358.
  2. Routray S*. Bowman Birk Inhibitors (BBI) in interception of inflammation and malignant transformation of OPMDs. Oral Oncol 2018 ;78.
  3. Routray S*, Kheur S, Chougule HM, Mohanty N, Dash R. Establishing Fascin over-expression as a strategic regulator of neoplastic aggression and lymph node metastasis in oral squamous cell carcinoma tumor microenvironment. Ann Diagn Pathol. 2017;30:36-41.
  4. Kumar R, Samal SK, Routray S, Dash R, Dixit A. Identification of oral cancer related candidate genes by integrating protein-protein interactions, gene ontology, pathway analysis and immunohistochemistry. Sci Rep. 2017;7(1):2472. Erratum in: Sci Rep. 2018;8(1):6454. Erratum in: Sci Rep. 2018;8(1):8356.
  5. Panda S, Padhiary SK, Routray S*. Chemokines accentuating protumoral activities in oral cancer microenvironment possess an imperious stratagem for therapeutic resolutions. Oral Oncol. 2016;60:8-17.
  6. Samal SK, Routray S, Veeramachaneni GK, Dash R, Botlagunta M. Ketorolac salt is a newly discovered DDX3 inhibitor to treat oral cancer. Sci Rep. 2015;5:9982.
  7. Routray S*. Use of phage display technique in treatment of HNSCC. Oral Oncol. 2014;50(9):e49- 50.
  8. Shankar AA, Alex S, Routray S*. Incorporation of salivary metabolomics in oral cancer diagnostics. Oral Oncol. 2014;50(10):e53-4.
  1. Routray S*. RAGE, inflammation and oral cancer: recreating the connexion. Oral Oncol. 2014;50(10):e58-9.
  2. Routray S*. Caveolin-1 in oral squamous cell carcinoma microenvironment: an overview. Tumour Biol. 2014;35(10):9487-95.
  3. Swain N, Kumar SV, Routray S, Pathak J, Patel S. Podoplanin–a novel marker in oral carcinogenesis. Tumour Biol. 2014;35(9):8407-13.
  4. Routray S*, Sunkavali A, Bari KA. Carcinoma-associated fibroblasts, its implication in head and neck squamous cell carcinoma: a mini review. Oral Dis. 2014;20(3):246-53.
  5. Routray S*, Mohanty N. Cancer stem cells accountability in progression of head and neck squamous cell carcinoma: the most recent trends! Mol Biol Int. 2014;2014:375325.
  6. Routray S*, Shankar AA, Swain N. Does entosis curb the detached cancer cells better? Oral Oncol. 2014;50(3):e9-11.
  7. Ingale Y, Shankar AA, Routray S, Agrawal M, Kadam A, Patil T. Ectopic teeth in ovarian teratoma: a rare appearance. Case Rep Dent. 2013;2013:970464.
  8. Ingale Y, Patil T, Chaudhari P, Routray S, Agrawal M. Granulocytic Sarcoma of Parotid Gland in a 4- Year-Old Child with Subleukemic AML: A Diagnostic Challenge! Case Rep Otolaryngol. 2013;2013:321289.
  9. Routray S*, Kheur SM, Kheur M. Osteopontin: a marker for invasive oral squamous cell carcinoma but not for potentially malignant epithelial dysplasias. Ann Diagn Pathol. 2013;17(5):421-4.
  10. Routray S*, Sunkavalli A, Swain N, Shankar AA. Emphasizing on heat shock protein 90’s utility in head and neck squamous cell carcinoma treatment. J Cancer Res Ther. 2013;9(4):583-6.
  11. Routray S*, Shankar AA. PET/CT: Emphasis and current utility in oral cancer. Oral Oncol. 2012;48(11):e42.
  12. Shankar AA, Routray S*. Trends in salivary diagnostics – a 5-year review of oral oncology (2007- 2011). Oral Oncol. 2012;48(6):e22-3.
  13. Routray S*, Motgi AS, Sunkavalli A. Comment on “Chole RH et al. Review of drug treatment of oral submucous fibrosis. Oral Oncol 2012; 48(5):393-398”. Oral Oncol. 2012;48(5):e13-4.
  14. Swain N, Kumar SV, Routray S, Richa. Reappraisal of photodynamic therapy as first-line therapy in management of oral pre-malignant lesions. Oral Oncology 01/2012; 48(10):915-16.
  15. Kheur SM, Routray S*. Comment on “Tumour infiltration depth P4 mm is an indication for an elective neck dissection in pT1cN0 oral squamous cell carcinoma” by Melchers et al., Oral Oncol 2012;48(4):337-42. Oral Oncol. 2012;48(6):e20-1.

National

  1. Verma S, Das S, Dasukil S, Routray S. Decrypting the occurrence of mucormycosis following dental extractions: A systematic review. J Mycol Med. 2023 May;33(2):101360.
  2. Dasukil S, Verma S, Routray S, Arora G, Boyina KK. Ranitidine: Is its injunction a warning bell? Indian J Pharmacol. 2021 Jan-Feb;53(1):80-81.
  3. Mishra S, Mohanty N, Routray S*, Misra S. Haemangiopericytoma/Solitary Fibrous Tumour of Mandible: An Uncommonness in the Oral Cavity. J Maxillofac Oral Surg. 2021;20(1):42-46.
  4. Routray S*, Mohanty N, Panda S, Sahoo SR. Hemangiopericytoma/solitaryfibrous tumor of mandible: A rare entity. J Oral Maxillofac Pathol. 2015;19(2):260-2.
  5. Routray S*, Majumdar S, Swain N. Ameloblastic carcinoma: An effort to abridge this diagnostic challenge! Indian J Cancer. 2015;52(2):234-5.
  6. Viswanath V, Routray S*. Tackling the delay: A unified approach. Indian J Cancer. 2015;52(1):92-3.
  7. Ingale Y, Routray S*, Kheur SM, Kheur M, Mohanty N. Evaluating the efficacy of osteopontin expression as a prognostic marker in oral squamous cell carcinoma in the Indian subpopulation. J Oral Maxillofac Pathol. 2014 ;18(Suppl 1):S11-5.
  8. Ingle Y, Shah A A, Kheur S, Routray S. Myoepithelial cell carcinoma of the oral cavity: A case report and review of literature. Journal of Oral and Maxillofacial Pathology 08/2014; 18(3):472.
  9. Mohanty S, Mohanty N, Routray S*, Misra SR, Vasudevan V. Calcifying epithelial odontogenic tumor, a rare presentation in children: two case reports. J Indian Soc Pedod Prev Dent. 2014;32(2):149-51.
  10. Mohanty N, Routray S*, Swain N, Ingale Y. Adenomatoid odontogenic tumor with clear cell changes. Indian J Pathol Microbiol. 2014;57(2):290-3.
  11. Ingale I, Routray S*, Kheur SM. Expansile congenital soft-tissue mass: a massive presentation. Indian J Pathol Microbiol. 2014;57(1):148-9.
  12. Satyabhusan NV, Routray S*, Bendi L, Suresh BV, Majumdar S, Mohanty N. Unicystic Ameloblastoma Masquerading as Huge Periapical Lesion, both Clinically and Histopathologically: Two Case Reports with Review of Literature. J Clin Imaging Sci. 2013;3(Suppl 1):9.
  13. Swain N, Kumar SV, Dhariwal R, Routray S. Primary fibrosarcoma of maxilla in an 8-year-old child: A rare entity. J Oral Maxillofac Pathol. 2013;17(3):478.
  14. Routray S, Rath S, Mohanty N. Prevalence of methicillin resistant Staphylococcus aureus isolated from saliva samples of patients with oral squamous cell carcinoma. J Oral Res.2019.
  15. Mishra S, Routray S*, Kumar Sahu S, Bhusan Nanda S, Charan Sahu K. The role and efficacy of herbal antimicrobial agents in orthodontic treatment. J Clin Diagn Res. 2014;8(6):ZC12-4.
  16. Mohanty N, Jalaluddin M, Kotina S, Routray S*, Ingale Y. Photodynamic therapy: the imminent milieu for treating oral lesions. J Clin Diagn Res. 2013;7(6):1254-7.
  17. Routray S*, Majumdar S. Ameloblastic carcinoma: Sometimes a challenge. J Oral Maxillofac Pathol. 2012;16(1):156-8.

Books

1.Dr Samapika Routray: Gene therapy in Oral Cancer. 08/2011; LAP. ISBN: 978-3-8465-9032-4.

2.Dr Samapika Routray (Editor)Microbes and Oral Squamous Cell Carcinoma-A Network Spanning

Infection and Inflammation.doi:https://doi.org/10.1007/978-981-19-0592-6.Publisher:Springer Singapore

Book Chapters

1.Podoplanin. Swain N, Routray S. Encyclopedia of Signaling Molecules, Edition: 2, Publisher: © Springer. March 2017

2.CD 44.Swain N, Routray S, Hosalkar R. Encyclopedia of Signaling Molecules, Edition: 2, Publisher: © Springer. March 2017

3.Caveolin-1. Routray S, Swain N, Hosalkar R. Encyclopedia of Signaling Molecules, Edition: 2, Publisher: © Springer. April 2017

4.Periostin. Routray S, Juber Rahman. Encyclopedia of Signaling Molecules, Edition: 2, Publisher: © Springer.April 2017

5.Syndecan-1. Swain N, Hosalkar R, Routray S. Encyclopedia of Signaling Molecules, Edition: 2, Publisher: © Springer. April 2017

6.Involucrin. Swain N, Hosalkar R, Routray S. Encyclopedia of Signaling Molecules, Edition: 2, Publisher: © Springer. April 2017

7.Proliferating Cell Nuclear Antigen. Hosalkar R, Swain N, Khivasara J, Routray S. Encyclopedia of Signaling Molecules, Edition: 2, Publisher: © Springer. May 2017

8.Keratin. Swain N, Routray S, Hosalkar R, Iyer J, Thakur M. Encyclopedia of Signaling Molecules, Edition: 2, Publisher: © Springer. August 2018

9.Implications and Future Perspectives Microbes and Oral Squamous Cell Carcinoma- .doi:https://doi.org/10.1007/978-981-19-0592-6.Publisher:Springer Singapore Jun 2022

10.Microbial dysbiosis in oral squamous cell carcinoma Microbes and Oral Squamous Cell Carcinoma- doi:https://doi.org/10.1007/978-981-19-0592-6.Publisher:Springer Singapore Jun 2022

 

Dr. Samapika Routray

Orcid ID

Scopus ID

Google Scholar ID

Researchgate ID

EXPERTISE INFORMATION
Research Group
Areas of Interest